Caris Life Sciences Collaborates with Genospace to Enhance Data Mining Capabilities to Advance the Molecular Understanding of Cancer

Expanded offering will increase biomarker insights from Caris Molecular Intelligence™ database and Caris Registry™

Irving, TX, Aug. 14, 2014 – Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced a collaboration with Genospace, a Massachusetts-based technology company that develops robust software solutions for genomic and health data.  Caris will apply Genospace’s population analytics offerings to uncover and better utilize key insights from the company’s industry-leading tumor profiling service, Caris Molecular Intelligence™. The partnership also leverages Genospace’s analytics architecture expertise to unlock key treatment insights from the Caris Registry™, a database of clinicopathologic and outcome variables from consenting patients whose tumors underwent multi-technology profiling by Caris.

Read more here.